Barrett's esophagus: The process of intestinalization

Problems in General Surgery

Volumn 18, Issue 2, 2001, Pages 31-42

  DeMeester, T R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; BILE ACID; BILE SALT; BILIRUBIN; CARCINOGEN; CIMETIDINE; CYCLOOXYGENASE 2; DIAZEPAM; DNA; FREE RADICAL; HYDROXYZINE; MUTAGENIC AGENT; NITRITE; NITROSAMINE; NITROSO DERIVATIVE; SUPEROXIDE DISMUTASE;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CARDIA; COLUMNAR EPITHELIUM; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; GASTROESOPHAGEAL REFLUX; GOBLET CELL; HUMAN; INTESTINE METAPLASIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH JUICE; STOMACH MUCOSA;

EID: 0035674169     PISSN: 07398328     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013452-200106000-00006     Document Type: Review

References (44)

1. The frequency of specialized intestinal metaplasia at the squamocolumnar junction varies with the extent of columnar epithelium lining the esophagus
2. Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease
3. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure
4. Endoscopic surveillance of columnar-lined esophagus: The frequency of intestinal metaplasia detection and impact of antireflux surgery
5. Barrett's esophagus in children: A histologic and histochemical study of 11 cases
6. Intestinal metaplasia is age related in Barrett's esophagus
7. Risk factors for Barrett's esophagus in community-based practice GORGE consortium. Gastroenterology outcomes research group in endoscopy
8. Regeneration of cardiac type mucosa and acquisition of Barrett's mucosa after esophago-gastrostomy
9. Gastroduodenal function in Barrett's esophagus
10. Implication of duodenogastric reflux in the pathogenesis of Barrett's esophagus
11. Complications of gastroesophageal reflux disease: Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux
12. Assessment of combined bile acid and pH profiles using an automated sampling devise in gastro-oesophageal reflux disease
13. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone: The need for surgical therapy re-emphasized
14. Determinants of interstinal metaplasia within the columnar-lined esophagus
15. Predictive factors of Barrett's esophagus-multivariate analysis of 502 patients with GERD
16. Dynamic effects of acid on Barrett's esophagus: An ex vivo proliferation and differentiation model
17. Distribution and significance of epithelial types in columnar lined esophagus
18. Factors influencing villus size in the small intestine of adult rats as revealed by transposition of intestinal segments
19. Contributions of bile and pancreatic juice to cell proliferation in ileal mucosa
20. The impact of an antireflux procedure on intestinal metaplasia of the cardia
21. Barrett's Esophagus
22. Bile reflux in benign and malignant Barrett's esophagus: Effect of medical acid suppression and Nissen fundoplication
23. Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux
24. Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux
25. Biology of gastroesophageal reflux disease: Pathophysiology relating to medical and surgical treatment
26. Bile acid accumulation by rabbit esophageal mucosa
27. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes; role of ATP depletion and cytosolic free calcium
28. Bile acids: Co-mutagenic activity in the salmonella-mammalian-microsom mutagenicity test: Brief communication
29. The mutagenic potential of duodeno-esophageal reflux
30. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
31. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats
32. Gastric juice protects against the development of esophageal adenocarcinoma in the rat
33. Esophagitis in Sprague-Dawley rates is mediated by free radicals
34. Free radical scavengers prevent reflux esophagitis in rats
35. Reflux esophagitis in humans is mediated by oxygen-derived free radicals
36. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
37. Oxidative damage in an esophageal adenocarcinoma model with rats
38. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole
39. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-Nitrosation
40. Effect of cimetidine on gastric juice N-Nitrosamine concentration
41. Metabolism of carcinogenic nitrosamines in the rate and human esophagus and induction of esophageal adenocarcinoma in rats
42. The etiology of gastric cancer: Intragastric Nitrosamide formation and other theories
43. N-Nitroso bile acid conjugates. 1. Synthesis, chemical reactivity and mutagenic activity
44. Columnar mucosa and intestinal metaplasia of the esophagus: Fifty years of controversy